Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Antisense compound for asthma shows promise

Feb. 21, 1997

Efficacy of leukotriene antagonist in asthma

Feb. 19, 1997

Pfizer claims 5-LO inhibitors

Feb. 13, 1997

Positive phase II results reported for LiquiVent

Feb. 12, 1997

Dual PDE IV/TNF inhibitors from Pfizer

Feb. 12, 1997

Merck Frosst discloses leukotriene antagonists

Feb. 12, 1997

Dual leukotriene/thromboxane antagonists described by Hokuriku

Feb. 10, 1997

Antiallergic/antiinflammatory agents from Senju

Feb. 7, 1997

Peptide derivatives with antiinflammatory properties described by U.S. researchers

Feb. 7, 1997

Egis develops 5-LO inhibitors

Feb. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
Research grants support early clinical trials of ALS treatments
BioWorld Science
The ALS Association has announced the recipients of its 2025 Hoffman ALS Clinical Trial Awards. These research grants, worth up to $1 million each, support...